BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

370 related articles for article (PubMed ID: 15447788)

  • 1. Neoadjuvant or adjuvant therapy for resectable esophageal cancer: a systematic review and meta-analysis.
    Malthaner RA; Wong RK; Rumble RB; Zuraw L;
    BMC Med; 2004 Sep; 2():35. PubMed ID: 15447788
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neoadjuvant treatments for locally advanced, resectable esophageal cancer: A network meta-analysis.
    Chan KKW; Saluja R; Delos Santos K; Lien K; Shah K; Cramarossa G; Zhu X; Wong RKS
    Int J Cancer; 2018 Jul; 143(2):430-437. PubMed ID: 29441562
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Preoperative chemotherapy for resectable thoracic esophageal cancer.
    Malthaner R; Fenlon D
    Cochrane Database Syst Rev; 2001; (1):CD001556. PubMed ID: 11279723
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hysterectomy with radiotherapy or chemotherapy or both for women with locally advanced cervical cancer.
    Kokka F; Bryant A; Brockbank E; Powell M; Oram D
    Cochrane Database Syst Rev; 2015 Apr; (4):CD010260. PubMed ID: 25847525
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Neoadjuvant therapy for resectable esophageal cancer].
    Hejna M; Raderer M
    Z Gastroenterol; 2005 Oct; 43(10):1141-7. PubMed ID: 16220454
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Survival after neoadjuvant chemotherapy or chemoradiotherapy for resectable oesophageal carcinoma: an updated meta-analysis.
    Sjoquist KM; Burmeister BH; Smithers BM; Zalcberg JR; Simes RJ; Barbour A; Gebski V;
    Lancet Oncol; 2011 Jul; 12(7):681-92. PubMed ID: 21684205
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A meta-analysis of randomized controlled trials that compared neoadjuvant chemoradiation and surgery to surgery alone for resectable esophageal cancer.
    Urschel JD; Vasan H
    Am J Surg; 2003 Jun; 185(6):538-43. PubMed ID: 12781882
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Survival benefits from neoadjuvant chemoradiotherapy or chemotherapy in oesophageal carcinoma: a meta-analysis.
    Gebski V; Burmeister B; Smithers BM; Foo K; Zalcberg J; Simes J;
    Lancet Oncol; 2007 Mar; 8(3):226-34. PubMed ID: 17329193
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preoperative chemotherapy for resectable thoracic esophageal cancer.
    Malthaner R; Fenlon D
    Cochrane Database Syst Rev; 2003; (4):CD001556. PubMed ID: 14583936
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Survival After Neoadjuvant and Adjuvant Treatments Compared to Surgery Alone for Resectable Esophageal Carcinoma: A Network Meta-analysis.
    Pasquali S; Yim G; Vohra RS; Mocellin S; Nyanhongo D; Marriott P; Geh JI; Griffiths EA
    Ann Surg; 2017 Mar; 265(3):481-491. PubMed ID: 27429017
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preoperative or postoperative therapy for resectable oesophageal cancer: an updated practice guideline.
    Malthaner R; Wong RK; Spithoff K;
    Clin Oncol (R Coll Radiol); 2010 May; 22(4):250-6. PubMed ID: 20398848
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neoadjuvant chemoradiotherapy for esophageal cancer: a review of meta-analyses.
    Wijnhoven BP; van Lanschot JJ; Tilanus HW; Steyerberg EW; van der Gaast A
    World J Surg; 2009 Dec; 33(12):2606-14. PubMed ID: 19760309
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Efficacy of Neoadjuvant Versus Adjuvant Therapy for Resectable Esophageal Cancer Patients: A Systematic Review and Meta-Analysis.
    Xiao X; Hong HG; Zeng X; Yang YS; Luan SY; Li Y; Chen LQ; Yuan Y
    World J Surg; 2020 Dec; 44(12):4161-4174. PubMed ID: 32761259
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neoadjuvant strategies in resectable carcinoma esophagus: a meta-analysis of randomized trials.
    Kumar T; Pai E; Singh R; Francis NJ; Pandey M
    World J Surg Oncol; 2020 Mar; 18(1):59. PubMed ID: 32199464
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A systematic review and network meta-analysis of neoadjuvant therapy combined with surgery for patients with resectable esophageal squamous cell carcinoma.
    Huang Y; Wang H; Luo G; Zhang Y; Wang L; Li K
    Int J Surg; 2017 Feb; 38():41-47. PubMed ID: 28027995
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A meta-analysis of randomized controlled trials that compared neoadjuvant chemotherapy and surgery to surgery alone for resectable esophageal cancer.
    Urschel JD; Vasan H; Blewett CJ
    Am J Surg; 2002 Mar; 183(3):274-9. PubMed ID: 11943125
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preoperative chemoradiotherapy for oesophageal cancer: a systematic review and meta-analysis.
    Fiorica F; Di Bona D; Schepis F; Licata A; Shahied L; Venturi A; Falchi AM; Craxì A; Cammà C
    Gut; 2004 Jul; 53(7):925-30. PubMed ID: 15194636
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of different neoadjuvant treatments for resectable locoregional esophageal cancer: A systematic review and network meta-analysis.
    Bao Y; Ma Z; Yuan M; Wang Y; Men Y; Hui Z
    Thorac Cancer; 2022 Sep; 13(17):2515-2523. PubMed ID: 35891585
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preoperative chemotherapy for resectable thoracic esophageal cancer.
    Kidane B; Coughlin S; Vogt K; Malthaner R
    Cochrane Database Syst Rev; 2015 May; 2015(5):CD001556. PubMed ID: 25988291
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neoadjuvant chemotherapy for resectable esophageal carcinoma: a meta-analysis of randomized clinical trials.
    Xu XH; Peng XH; Yu P; Xu XY; Cai EH; Guo P; Li K
    Asian Pac J Cancer Prev; 2012; 13(1):103-10. PubMed ID: 22502650
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.